Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target
Severe COVID-19 is characterized by acute respiratory distress syndrome (ARDS)-like hyperinflammation and endothelial dysfunction, that can lead to respiratory and multi organ failure and death. Interstitial lung diseases (ILD) and pulmonary fibrosis confer an increased risk for severe disease, whil...
Main Authors: | Konstantinos Ntatsoulis, Theodoros Karampitsakos, Eliza Tsitoura, Elli-Anna Stylianaki, Alexios N. Matralis, Argyrios Tzouvelekis, Katerina Antoniou, Vassilis Aidinis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.687397/full |
Similar Items
-
Autotaxin in Pathophysiology and Pulmonary Fibrosis
by: Ioanna Ninou, et al.
Published: (2018-06-01) -
Expression of proteins related to autotaxin–lysophosphatidate signaling in thyroid tumors
by: Eunah Shin, et al.
Published: (2019-08-01) -
Autotaxin Has a Negative Role in Systemic Inflammation
by: Ioanna Nikitopoulou, et al.
Published: (2022-07-01) -
Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
by: Matteo Centonze, et al.
Published: (2023-08-01) -
Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer
by: Sha She, et al.
Published: (2022-06-01)